Pathway, a clinical decision support platform, announced it raised $1.3 million to scale its clinical decision support platform. Investors include Panache Ventures, Amplify Capital, Desjardins

Pathway, a clinical decision support platform, announced it raised $1.3 million to scale its clinical decision support platform. Investors include Panache Ventures, Amplify Capital, Desjardins
Activ Surgical, a surgical intelligence software powered by machine learning, raised $45 million in a Series B financing round led by Cota Capital, an investment
Astarte Medical, a clinical intelligence company, using software and predictive analytics to improve infant care, secured $7.6 million in Series A-1 financing. Investors in the
Eleos Health, an AI-powered clinical decision-making technology for behavioral health providers, secured $6 million in seed funding. aMoon Fund led the round with lool ventures,
Overjet, an AI-powered dental assistant tool, raised $27 million in Series A financing led by General Catalyst, Insight Partners, with existing investors, including Crosslink Capital
Venture capital (VC) funding into Clinical Decision Support software companies doubled to $1.1 billion in the First Half (1H) of 2021, compared to $545 million
Iterative Scopes, an AI-powered precision medicine software for endoscopic images, closed a $30 million Series A financing round. The round was led by new investor
HeartFlow, a precision heart care platform, and Longview Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, announced that
xCures, an AI-powered precision oncology platform, raised $12.69 million in Series A funding, led by Boehringer Ingelheim Venture Fund. Vanedge Capital, Harmonix Fund, and Metaplanet
Etiometry, a clinical decision-support software for the intensive care environment, announced a fully subscribed $9 million Series A-3 extension raise. The latest round of funding